CytomX Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CTMX for the last quarter is 26.61 M USD, and it's 0.85% higher compared to the previous quarter. The net income of Q4 23 is 837.00 k USD.